Details for 2018753256
Up to date per 08.05.2026
Actions
Details for 2018753256
Granted/Registered
European Patent
29.04.2020 A
28.12.2022 B1
20.06.2017
US
201762522157 P
A61K 31/415 20060101AFI20211119BHEP
Owner
Neurosense Therapeutics Ltd.85 Medinat Hayehudim 4676670 HerzeliyaIL
Representative
Authorized Recipients
Paul CosmoviciGumpendorfer Straße 1421060 WienAT
Inventor
BEN-NOON, Alon24 Bialik Blvd 4720807 Ramat HaSharonIL
Information about Fees